USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ALBA THERAPEUTICS CORPORATION
Address:
2400 BOSTON STREET
SUITE 334
BALTIMORE, MD 21224
Phone:
(410) 522-8708
URL:
N/A
EIN:
201131818
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $265,312.00 1

Award List:

Oral Formulation of Zonulin Antagonist AT-1001 for Diabe

Award Year / Program / Phase:
2006 / STTR / Phase I
Award Amount:
$265,312.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The trigger for autoimmune destruction of pancreatic beta cells in Type 1 diabetes (T1D) is unclear. Evidence exists for the role of increased intestinal permeability, secondary to intestinal tight junctions (tj) disassembly, in the pathogenesis of various… More